{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT05616013","recordId":"NCT05616013","peptideSlug":"semaglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05616013-semaglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct05616013.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct05616013.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2022-11-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2022-11-09","publishedAt":"2026-08-23","recordId":"NCT05616013","recordSha256":"c551b5ef1a43054167acf80b0e82737228d72666d06579c02ead3531071d8cb2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05616013?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2022-12-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"semaglutide","submittedDate":"2022-12-19","publishedAt":"2026-08-23","recordId":"NCT05616013","recordSha256":"9228af95c272fedf8e29b652461184ddd2337f1430ea2f2ad0e7d862f72b9563","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05616013?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Outcome Measures","Study Description","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2023-01-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"semaglutide","submittedDate":"2023-01-10","publishedAt":"2026-08-23","recordId":"NCT05616013","recordSha256":"2c34248a84a301743f3f094c18031fd7909d51137419cc264709022a1dfe7faa","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05616013?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2023-02-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"semaglutide","submittedDate":"2023-02-01","publishedAt":"2026-08-23","recordId":"NCT05616013","recordSha256":"56e43a1848fcad305de2a31af5cf7822ceaa6b29888467ee9a765084ef0989a7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05616013?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2023-02-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"semaglutide","submittedDate":"2023-02-09","publishedAt":"2026-08-23","recordId":"NCT05616013","recordSha256":"f22e3b058136975bec5001094340e35293bd6662348fc62c8c207988e534b5d1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05616013?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2023-03-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"semaglutide","submittedDate":"2023-03-09","publishedAt":"2026-08-23","recordId":"NCT05616013","recordSha256":"53d146df7dd651d867621146de27f86ed359ee519f3b72a6662a79f5ea38e850","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05616013?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2023-04-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"semaglutide","submittedDate":"2023-04-13","publishedAt":"2026-08-23","recordId":"NCT05616013","recordSha256":"98ab730d94b8a65ca39e0d6b54e713a8b5df80efd2d056becba0d3c56a0ef839","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05616013?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2023-04-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"semaglutide","submittedDate":"2023-04-26","publishedAt":"2026-08-23","recordId":"NCT05616013","recordSha256":"5bb9eef9e42b88beee6806e44ec58e00336c0639757769450454c9cab925b596","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05616013?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2023-05-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2023-05-02","publishedAt":"2026-08-23","recordId":"NCT05616013","recordSha256":"fc1b40818b7919dcf8242426041a1de121fedfc8249da90c849d50818a600d4f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05616013?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Eligibility","Outcome Measures","Study Design","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2023-05-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2023-05-25","publishedAt":"2026-08-23","recordId":"NCT05616013","recordSha256":"7f7342a1aa7e0917b1c081b7f769786f4bf35378099848f5474f2da4e90e40aa","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05616013?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Sponsor/Collaborators","Study Design","Study Identification","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2023-11-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2023-11-09","publishedAt":"2026-08-23","recordId":"NCT05616013","recordSha256":"18368f9e5192083065003d7bac32dcbe9ab0b5f06593690f00d70f89c1796163","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05616013?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Identification","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2024-01-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2024-01-31","publishedAt":"2026-08-23","recordId":"NCT05616013","recordSha256":"1546b47f5b5b25fd48b8c8a4bd6217f76c33ee89405a8adc3557e4ad953efa83","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05616013?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2024-07-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2024-07-01","publishedAt":"2026-08-23","recordId":"NCT05616013","recordSha256":"883edadd29e358f1278bb98ea9e835ca6721688e48799d344f6cfd84392fc7ee","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05616013?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2024-08-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2024-08-28","publishedAt":"2026-08-23","recordId":"NCT05616013","recordSha256":"f6a8600d47dfd8e769c17c41fef0416ca00d628b34a47b116dc6960c285c0cd8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05616013?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","IPDSharing","Outcome Measures","Study Design","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2024-12-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2024-12-13","publishedAt":"2026-08-23","recordId":"NCT05616013","recordSha256":"1b047a0fc4dc862ed780847a1bd70cedf95064f2aa0463eab6299c8e98f8e57c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05616013?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2025-01-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2025-01-22","publishedAt":"2026-08-23","recordId":"NCT05616013","recordSha256":"bb194e30c27b356c860a4019080d4a4a4b2f0e21f7b358f9d3816f845a23a329","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05616013?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2025-02-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2025-02-27","publishedAt":"2026-08-23","recordId":"NCT05616013","recordSha256":"daa51dd3f3c638b58412d43b32313c8f14bd5d2cc51e7076e31c295202c9682d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05616013?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Document Section","Outcome Measures (Results)","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2025-06-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"semaglutide","submittedDate":"2025-06-27","publishedAt":"2026-08-23","recordId":"NCT05616013","recordSha256":"5c8aa894175986fbae10322cb2015b2c1b105c7714f36a0cf83654af6eb49c95","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05616013?a=19&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2026-06-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"semaglutide","submittedDate":"2026-06-11","publishedAt":"2026-08-23","recordId":"NCT05616013","recordSha256":"a4cd5ffabcd5738f02f1e7b25da9069cbbc3e3cdff21733d6d1c02464c452fd9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05616013?a=20&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"2313fe9acd620916a40a91e9c98cb690ad028773a0d092c5987913143ade4588"}}